Printed from www.actionpf.org

Sign up to the APF Newsletter to keep informed about our latest work
Take part in research

Find a research study

Ask your healthcare team about taking part in research

Explore the Study Finder to learn about research that is happening in the UK today. You may be able to take part.

Need help? Take a look at our information guide.

Are you a researcher currently recruiting participants in the UK? If you would like your study included on this page, please complete this online form.

View by status:
More filter options
Reset filters
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis
Healthy volunteers
Northern Ireland
Wales
Scotland
England
Further explanation
Trial phase

There are 3 main phases of clinical trials:

  • Phase 1 is the earliest stage of research, where there is often a focus on understanding if the treatment is safe or if it causes any side effects.
  • Phase 2 still focuses on safety and side effects, but also tries to find out more about what is the best dose.
  • Phase 3 often compares the new treatment to existing treatments or lookalike medications.

As drugs or interventions move into the different phases, the number of people taking part will increase. Not all studies will make it to the later phases, especially if the intervention is not found to be safe or effective in phase 1 and 2.

Further explanation
Trial phase

There are 3 main phases of clinical trials:

  • Phase 1 is the earliest stage of research, where there is often a focus on understanding if the treatment is safe or if it causes any side effects.
  • Phase 2 still focuses on safety and side effects, but also tries to find out more about what is the best dose.
  • Phase 3 often compares the new treatment to existing treatments or lookalike medications.

As drugs or interventions move into the different phases, the number of people taking part will increase. Not all studies will make it to the later phases, especially if the intervention is not found to be safe or effective in phase 1 and 2.

Further explanation
Trial phase

There are 3 main phases of clinical trials:

  • Phase 1 is the earliest stage of research, where there is often a focus on understanding if the treatment is safe or if it causes any side effects.
  • Phase 2 still focuses on safety and side effects, but also tries to find out more about what is the best dose.
  • Phase 3 often compares the new treatment to existing treatments or lookalike medications.

As drugs or interventions move into the different phases, the number of people taking part will increase. Not all studies will make it to the later phases, especially if the intervention is not found to be safe or effective in phase 1 and 2.

Further explanation
Open-label extension

Some studies offer an extension phase of research, where people continue to receive the new drug or therapy after the initial trial has finished. The extension phase is often ‘open-label’, which means that you will know that you are receiving the active treatment .

Further explanation
Can continue on antifibrotics

Within studies, there are different requirements that someone must meet, to be able to take part. Some studies recruit people who are taking antifibrotic medications, including nintedanib or pirfenidone. However, in other studies people taking part must not be taking antifibrotic medication.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
0
 result/s
Tag

Can nerandomilast help people with lung fibrosis related to rheumatic diseases?

Results available
Upcoming
Recruiting
Closed
7.5 -13 months
participation
7.5 -13 months
participation
A study to test if a new drug, nerandomilast, can help people with lung fibrosis related to rheumatic diseases

People affected by pulmonary fibrosis (PF) which is linked to their rheumatic disease, currently have limited treatment options to slow the progression. New research studies are needed to gain valuable knowledge about potentially better treatment options.

This study is a randomised controlled trial which tests the impact of nerandomilast to see how this differs to a placebo, which is a lookalike medication that doesn't contain any active drug ingredients. It can sometimes be referred to as a dummy medicine.

‍The main aim of this study is to find out how a drug called nerandomilast affects the lungs in people with systemic autoimmune rheumatic disease.

Taking a drug
Hospital visits
England
Northern Ireland
III
Other forms of pulmonary fibrosis

How can digital health strategies support managing respiratory care?

Results available
Upcoming
Recruiting
Closed
20 minutes
participation
20 minutes
participation
Online survey to explore the impact of using digital health for respiratory conditions

The purpose of this survey is to explore the potential impact of using digital health for respiratory conditions on access to, and delivery of care, in NHS settings. By Digital Health, it means the use of technology to assist in receiving care remotely, where individuals and the healthcare providers are at distance, and not in person contact. This can be through phone calls, video calls, text messages, applications, or any type of device to record your medical information. It allows patients to share health information, contact their healthcare team, or have appointments through video calls. Whether you are a user of digital health or not, the researchers are interested in learning more about your respiratory condition and/or your perspectives on digital health.

The researchers hope that this survey will help to understand the role of digital health in managing care for individuals with respiratory diseases in the UK.

Survey
Online only
England
Scotland
Wales
Northern Ireland
Idiopathic Pulmonary Fibrosis (IPF)
Other forms of pulmonary fibrosis
No match for these filter settings

APF does not endorse or recommend any specific study. All responsibility for the study remains with the sponsors and investigators. You may still be able to take part if studies aren't local to you. Every effort is made to keep these details up to date. If you are aware of any inaccuracies, please email research@actionpf.org. You may also request for a study to be added.

This page is under development. We welcome your feedback! Please email research@actionpf.org.

Are you a researcher currently recruiting participants in the UK? If you would like your study included on this page, please complete this online form.

Can't find anything that interests you? Check back soon as we regularly update these pages.